VariZIG FDA Approval History
FDA Approved: Yes (First approved December 20, 2012)
Brand name: VariZIG
Generic name: varicella zoster immune globulin
Dosage form: for Injection
Company: Cangene Corporation
Treatment for: Varicella-Zoster
VariZIG is a varicella zoster immune globulin (human) intended to reduce the severity of chickenpox (varicella) infections in high risk individuals.
Development Timeline for VariZIG
|Dec 21, 2012||ApprovalFDA Approves Varizig for Reducing Chickenpox Symptoms|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.